US3798209A
(en)
|
1971-06-01 |
1974-03-19 |
Icn Pharmaceuticals |
1,2,4-triazole nucleosides
|
USRE29835E
(en)
|
1971-06-01 |
1978-11-14 |
Icn Pharmaceuticals |
1,2,4-Triazole nucleosides
|
US3852267A
(en)
|
1972-08-04 |
1974-12-03 |
Icn Pharmaceuticals |
Phosphoramidates of 3{40 ,5{40 -cyclic purine nucleotides
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
NL8403224A
(nl)
|
1984-10-24 |
1986-05-16 |
Oce Andeno Bv |
Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
GB8719367D0
(en)
|
1987-08-15 |
1987-09-23 |
Wellcome Found |
Therapeutic compounds
|
EP0380558A4
(en)
|
1987-09-22 |
1991-07-31 |
The Regents Of The University Of California |
Liposomal nucleoside analogues for treating aids
|
IL91664A
(en)
|
1988-09-28 |
1993-05-13 |
Yissum Res Dev Co |
Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
|
US6132763A
(en)
|
1988-10-20 |
2000-10-17 |
Polymasc Pharmaceuticals Plc |
Liposomes
|
US5705363A
(en)
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
US5411947A
(en)
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
US5194654A
(en)
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
US5463092A
(en)
|
1989-11-22 |
1995-10-31 |
Vestar, Inc. |
Lipid derivatives of phosphonacids for liposomal incorporation and method of use
|
US5026687A
(en)
|
1990-01-03 |
1991-06-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
|
DE69132332T2
(de)
|
1990-04-06 |
2000-11-30 |
Genelabs Tech Inc |
Hepatitis c-virus-epitope
|
AU7872491A
(en)
|
1990-05-07 |
1991-11-27 |
Vical, Inc. |
Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
|
JPH05507279A
(ja)
|
1990-05-29 |
1993-10-21 |
ネクススター・ファーマシューティカルズ・インコーポレイテッド |
グリセロールジ―およびトリホスフェート誘導体の合成
|
CA2083386C
(en)
|
1990-06-13 |
1999-02-16 |
Arnold Glazier |
Phosphorous prodrugs
|
US6060080A
(en)
|
1990-07-16 |
2000-05-09 |
Daiichi Pharmaceutical Co., Ltd. |
Liposomal products
|
JP2599492B2
(ja)
|
1990-08-21 |
1997-04-09 |
第一製薬株式会社 |
リポソーム製剤の製造法
|
US5372808A
(en)
|
1990-10-17 |
1994-12-13 |
Amgen Inc. |
Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
|
US5543389A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization |
Covalent polar lipid-peptide conjugates for use in salves
|
US5149794A
(en)
|
1990-11-01 |
1992-09-22 |
State Of Oregon |
Covalent lipid-drug conjugates for drug targeting
|
US5256641A
(en)
|
1990-11-01 |
1993-10-26 |
State Of Oregon |
Covalent polar lipid-peptide conjugates for immunological targeting
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
US5595732A
(en)
|
1991-03-25 |
1997-01-21 |
Hoffmann-La Roche Inc. |
Polyethylene-protein conjugates
|
US5157027A
(en)
|
1991-05-13 |
1992-10-20 |
E. R. Squibb & Sons, Inc. |
Bisphosphonate squalene synthetase inhibitors and method
|
CA2112803A1
(en)
|
1991-07-12 |
1993-01-21 |
Karl Y. Hostetler |
Antiviral liponucleosides: treatment of hepatitis b
|
US5554728A
(en)
|
1991-07-23 |
1996-09-10 |
Nexstar Pharmaceuticals, Inc. |
Lipid conjugates of therapeutic peptides and protease inhibitors
|
TW224053B
(pt)
|
1991-09-13 |
1994-05-21 |
Paul B Chretien |
|
US5676942A
(en)
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
US5405598A
(en)
|
1992-02-24 |
1995-04-11 |
Schinazi; Raymond F. |
Sensitizing agents for use in boron neutron capture therapy
|
JP3102945B2
(ja)
|
1992-02-27 |
2000-10-23 |
財団法人野田産業科学研究所 |
肝炎治療剤
|
US5610054A
(en)
|
1992-05-14 |
1997-03-11 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatic RNA molecule targeted against Hepatitis C virus
|
BR9302427A
(pt)
|
1992-06-22 |
1994-01-11 |
Lilly Co Eli |
Processo estereo seletivo para a preparacao de um derivado de riboturanosila
|
US5426183A
(en)
|
1992-06-22 |
1995-06-20 |
Eli Lilly And Company |
Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
|
US5256798A
(en)
|
1992-06-22 |
1993-10-26 |
Eli Lilly And Company |
Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
|
TW356472B
(en)
|
1992-09-01 |
1999-04-21 |
Lilly Co Eli |
A process for anomerizing nucleosides
|
GB9226729D0
(en)
|
1992-12-22 |
1993-02-17 |
Wellcome Found |
Therapeutic combination
|
AU6247594A
(en)
|
1993-02-24 |
1994-09-14 |
Jui H. Wang |
Compositions and methods of application of reactive antiviral polymers
|
US6180134B1
(en)
|
1993-03-23 |
2001-01-30 |
Sequus Pharmaceuticals, Inc. |
Enhanced ciruclation effector composition and method
|
AU701574B2
(en)
|
1993-05-12 |
1999-02-04 |
Karl Y. Hostetler |
Acyclovir derivatives for topical use
|
WO1995003056A1
(fr)
|
1993-07-19 |
1995-02-02 |
Tokyo Tanabe Company Limited |
Inhibiteur de proliferation du virus de l'hepatite c
|
US7375198B2
(en)
|
1993-10-26 |
2008-05-20 |
Affymetrix, Inc. |
Modified nucleic acid probes
|
US6156501A
(en)
|
1993-10-26 |
2000-12-05 |
Affymetrix, Inc. |
Arrays of modified nucleic acid probes and methods of use
|
US5951974A
(en)
|
1993-11-10 |
1999-09-14 |
Enzon, Inc. |
Interferon polymer conjugates
|
HUT75533A
(en)
|
1993-11-10 |
1997-05-28 |
Schering Corp |
Improved interferon polymer conjugates
|
WO1995024185A1
(en)
|
1994-03-11 |
1995-09-14 |
Isis Pharmaceuticals, Inc. |
Novel pyrimidine nucleosides
|
DE4447588C2
(de)
|
1994-05-03 |
1997-11-20 |
Omer Osama Dr Dr Med |
Pflanzliches Arzneimittel zur Behandlung von chronischen und allergischen Rhino-Sino-Bronchitiden
|
CA2192950A1
(en)
|
1994-06-22 |
1995-12-28 |
Danny P.C. Mcgee |
Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement
|
DE4432623A1
(de)
|
1994-09-14 |
1996-03-21 |
Huels Chemische Werke Ag |
Verfahren zur Bleichung von wäßrigen Tensidlösungen
|
US5738846A
(en)
|
1994-11-10 |
1998-04-14 |
Enzon, Inc. |
Interferon polymer conjugates and process for preparing the same
|
US5696277A
(en)
|
1994-11-15 |
1997-12-09 |
Karl Y. Hostetler |
Antiviral prodrugs
|
US5703058A
(en)
|
1995-01-27 |
1997-12-30 |
Emory University |
Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
|
US6391859B1
(en)
|
1995-01-27 |
2002-05-21 |
Emory University |
[5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
|
DE59609590D1
(de)
|
1995-02-01 |
2002-10-02 |
Resprotect Gmbh |
Verwendung von 5' substituierten nukleosiden zur hemmung von resistenzbildung bei der zytostatikabehandlung
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
DE19514523A1
(de)
|
1995-04-12 |
1996-10-17 |
Schering Ag |
Neue Cytosin- und Cytidinderivate
|
WO1997012033A1
(en)
|
1995-09-27 |
1997-04-03 |
Emory University |
Recombinant hepatitis c virus rna replicase
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
US5767097A
(en)
|
1996-01-23 |
1998-06-16 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
|
GB9602028D0
(en)
|
1996-02-01 |
1996-04-03 |
Amersham Int Plc |
Nucleoside analogues
|
US5980884A
(en)
|
1996-02-05 |
1999-11-09 |
Amgen, Inc. |
Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon
|
EP0914421A2
(en)
|
1996-02-29 |
1999-05-12 |
Immusol, Inc. |
Hepatitis c virus ribozymes
|
US5633388A
(en)
|
1996-03-29 |
1997-05-27 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment of hepatitis C
|
US5830905A
(en)
|
1996-03-29 |
1998-11-03 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment of hepatitis C
|
US5990276A
(en)
|
1996-05-10 |
1999-11-23 |
Schering Corporation |
Synthetic inhibitors of hepatitis C virus NS3 protease
|
GB9609932D0
(en)
|
1996-05-13 |
1996-07-17 |
Hoffmann La Roche |
Use of IL-12 and IFN alpha for the treatment of infectious diseases
|
US5891874A
(en)
|
1996-06-05 |
1999-04-06 |
Eli Lilly And Company |
Anti-viral compound
|
US5837257A
(en)
|
1996-07-09 |
1998-11-17 |
Sage R&D |
Use of plant extracts for treatment of HIV, HCV and HBV infections
|
US5858389A
(en)
*
|
1996-08-28 |
1999-01-12 |
Shaker H. Elsherbini |
Squalene is an antiviral compound for treating hepatitis C virus carriers
|
US5922757A
(en)
|
1996-09-30 |
1999-07-13 |
The Regents Of The University Of California |
Treatment and prevention of hepatic disorders
|
US6455690B1
(en)
|
1996-10-16 |
2002-09-24 |
Robert Tam |
L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine
|
WO1998016186A2
(en)
|
1996-10-16 |
1998-04-23 |
Icn Pharmaceuticals, Inc. |
Monocyclic l-nucleosides, analogs and uses thereof
|
US6509320B1
(en)
|
1996-10-16 |
2003-01-21 |
Icn Pharmaceuticals, Inc. |
Purine L-nucleosides, analogs and uses thereof
|
CN1233254A
(zh)
|
1996-10-16 |
1999-10-27 |
Icn药品公司 |
嘌呤l-核苷、其类似物及其用途
|
CZ298749B6
(cs)
|
1996-10-18 |
2008-01-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitory serinových proteáz a farmaceutické prostředky s jejich obsahem
|
GB9623908D0
(en)
|
1996-11-18 |
1997-01-08 |
Hoffmann La Roche |
Amino acid derivatives
|
IL119833A
(en)
|
1996-12-15 |
2001-01-11 |
Lavie David |
Hypericum perforatum extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
|
US6004933A
(en)
|
1997-04-25 |
1999-12-21 |
Cortech Inc. |
Cysteine protease inhibitors
|
PL193237B1
(pl)
|
1997-06-30 |
2007-01-31 |
Merz Pharma Gmbh & Co Kgaa |
Pochodne 1-aminoalkilocykloheksanu, kompozycja farmaceutyczna je zawierająca oraz ich zastosowanie
|
ATE283865T1
(de)
|
1997-08-11 |
2004-12-15 |
Boehringer Ingelheim Ca Ltd |
Peptidanaloga mit inhibitorischer wirkung auf hepatitis c
|
ES2287971T3
(es)
|
1997-08-11 |
2007-12-16 |
Pfizer Products Inc. |
Dispersiones farmaceuticas solidas con biodisponibilidad incrementada.
|
ES2162393T3
(es)
|
1997-09-21 |
2001-12-16 |
Schering Corp |
Terapia de combinacion para erradicar el hcv-rna detectable en pacientes con infeccion de hepatitis c cronica.
|
US6703374B1
(en)
|
1997-10-30 |
2004-03-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nucleosides for imaging and treatment applications
|
US5981709A
(en)
|
1997-12-19 |
1999-11-09 |
Enzon, Inc. |
α-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same
|
US7462605B2
(en)
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
WO1999037753A1
(en)
|
1998-01-23 |
1999-07-29 |
Newbiotics, Inc. |
Enzyme catalyzed therapeutic agents
|
EP1058686B1
(en)
|
1998-02-25 |
2006-11-02 |
Emory University |
2'-fluoronucleosides
|
US6787305B1
(en)
|
1998-03-13 |
2004-09-07 |
Invitrogen Corporation |
Compositions and methods for enhanced synthesis of nucleic acid molecules
|
WO1999049873A1
(en)
|
1998-03-27 |
1999-10-07 |
Regents Of The University Of Minnesota |
Nucleosides with antiviral and anticancer activity
|
GB9806815D0
(en)
|
1998-03-30 |
1998-05-27 |
Hoffmann La Roche |
Amino acid derivatives
|
KR100694345B1
(ko)
|
1998-05-15 |
2007-03-12 |
쉐링 코포레이션 |
리바비린 및 인터페론 알파를 포함하는, 만성 c형 간염에 걸린 항-바이러스 치료에 대한 나이브 환자의 치료용 약제학적 조성물
|
KR20010052622A
(ko)
|
1998-06-08 |
2001-06-25 |
프리돌린 클라우스너, 롤란드 비. 보레르 |
만성 씨형 간염을 치료하기 위한 폴리에틸렌글리콜-인터페론-알파 및 리바비린의 용도
|
DE69925918T2
(de)
|
1998-07-27 |
2006-05-11 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Diketosäure-derivate als hemmstoffe von polymerasen
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
AU5475799A
(en)
|
1998-08-10 |
2000-03-06 |
Centre National De La Recherche Scientifique |
Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis
|
EP1140143A2
(en)
|
1998-12-18 |
2001-10-10 |
Schering Corporation |
Ribavirin-pegylated interferon alfa induction hcv combination therapy
|
ES2307482T3
(es)
|
1999-02-10 |
2008-12-01 |
Pfizer Products Inc. |
Dispersiones farmaceuticas solidas.
|
EP1200455B1
(en)
|
1999-07-22 |
2009-04-22 |
Celmed Oncology (USA), Inc. |
Enzyme catalyzed therapeutic activation
|
WO2001032153A2
(en)
|
1999-11-04 |
2001-05-10 |
Shire Biochem Inc. |
Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
|
EP1232166A2
(en)
|
1999-11-12 |
2002-08-21 |
Pharmasset Limited |
Synthesis of 2'-deoxy-l-nucleosides
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
AU2001235278A1
(en)
|
2000-02-18 |
2001-08-27 |
Shire Biochem Inc |
Method for the treatment or prevention of flavivirus infections using nucleoside analogues
|
JP2003532643A
(ja)
|
2000-04-13 |
2003-11-05 |
フアーマセツト・リミテツド |
肝炎ウイルス感染症を治療するための3’−または2’−ヒドロキシメチル置換ヌクレオシド誘導体
|
US6924270B2
(en)
|
2000-04-20 |
2005-08-02 |
Schering Corporation |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
OA12382A
(en)
|
2000-05-26 |
2006-04-17 |
Novirio Pharmaceuticals Ltd |
Methods and compositions for treating flavivirusesand pestiviruses.
|
ATE275406T1
(de)
|
2000-05-26 |
2004-09-15 |
Idenix Cayman Ltd |
Methoden zur behandlung von delta hepatitis virus infektionen mit beta-l-2' deoxy-nucleosiden
|
FR2810322B1
(fr)
|
2000-06-14 |
2006-11-10 |
Pasteur Institut |
PRODUCTION COMBINATOIRE D'ANALOGUES DE NUCLEOTIDES ET NUCLEOTIDES (XiTP)
|
MY141594A
(en)
|
2000-06-15 |
2010-05-14 |
Novirio Pharmaceuticals Ltd |
3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
CA2418199A1
(en)
|
2000-07-21 |
2002-01-31 |
Corvas International, Inc. |
Peptides as ns3-serine protease inhibitors of hepatitis c virus
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
AR034127A1
(es)
|
2000-07-21 |
2004-02-04 |
Schering Corp |
Imidazolidinonas como inhibidores de ns3-serina proteasa del virus de hepatitis c, composicion farmaceutica, un metodo para su preparacion, y el uso de las mismas para la manufactura de un medicamento
|
AU8063701A
(en)
|
2000-07-21 |
2002-02-05 |
Schering Corp |
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
|
ES2536972T5
(es)
|
2000-07-21 |
2022-04-06 |
Gilead Sciences Inc |
Profármacos de análogos de nucleótidos de fosfonato y métodos para seleccionar y preparar los mismos
|
US6897201B2
(en)
|
2000-08-21 |
2005-05-24 |
Inspire Pharmaceuticals, Inc. |
Compositions and methods for the treatment of glaucoma or ocular hypertension
|
US7018985B1
(en)
|
2000-08-21 |
2006-03-28 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
AR039558A1
(es)
|
2000-08-21 |
2005-02-23 |
Inspire Pharmaceuticals Inc |
Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
DE10046541A1
(de)
|
2000-09-19 |
2002-03-28 |
Knoll Ag |
Mechanisch stabile darreichungsformen, enthaltend Ubichinone
|
JP2004511513A
(ja)
|
2000-10-18 |
2004-04-15 |
シェリング・コーポレーション |
リバビリン−PEG化インターフェロンαHCV併用治療
|
KR100905221B1
(ko)
|
2000-10-18 |
2009-07-01 |
파마셋 인코포레이티드 |
바이러스 감염 및 비정상적인 세포 증식의 치료를 위한변형된 뉴클레오시드
|
US6555677B2
(en)
|
2000-10-31 |
2003-04-29 |
Merck & Co., Inc. |
Phase transfer catalyzed glycosidation of an indolocarbazole
|
CA2429359A1
(en)
|
2000-11-20 |
2002-08-08 |
Bristol-Myers Squibb Company |
Hepatitis c tripeptide inhibitors
|
MXPA03005219A
(es)
|
2000-12-12 |
2003-09-25 |
Schering Corp |
Peptidos diarilicos como inhibidores de ns3-serina proteasa en hepatitis de virus c.
|
US6727366B2
(en)
|
2000-12-13 |
2004-04-27 |
Bristol-Myers Squibb Pharma Company |
Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
|
WO2002048116A2
(en)
|
2000-12-13 |
2002-06-20 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
CN1527836A
(zh)
|
2000-12-15 |
2004-09-08 |
|
用于治疗黄病毒科病毒感染的抗病毒剂
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
EP1355916B1
(en)
|
2001-01-22 |
2007-01-10 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
GB0112617D0
(en)
|
2001-05-23 |
2001-07-18 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
JP2004534830A
(ja)
|
2001-06-21 |
2004-11-18 |
グラクソ グループ リミテッド |
Hcvにおけるヌクレオシド化合物
|
KR100926244B1
(ko)
|
2001-07-11 |
2009-11-12 |
버텍스 파마슈티칼스 인코포레이티드 |
브릿지된 바이사이클릭 세린 프로테아제 억제제
|
US6841566B2
(en)
|
2001-07-20 |
2005-01-11 |
Boehringer Ingelheim, Ltd. |
Viral polymerase inhibitors
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
US6962991B2
(en)
|
2001-09-12 |
2005-11-08 |
Epoch Biosciences, Inc. |
Process for the synthesis of pyrazolopyrimidines
|
WO2003022861A1
(en)
|
2001-09-13 |
2003-03-20 |
Bristol-Myers Squibb Company |
Process for the preparation of rebeccamycin and analogs thereof
|
WO2003024461A1
(en)
|
2001-09-20 |
2003-03-27 |
Schering Corporation |
Hcv combination therapy
|
WO2003026589A2
(en)
|
2001-09-28 |
2003-04-03 |
Idenix (Cayman) Limited |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
EP1440069B1
(en)
|
2001-11-02 |
2007-08-15 |
Glaxo Group Limited |
4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
|
GB0129945D0
(en)
|
2001-12-13 |
2002-02-06 |
Mrc Technology Ltd |
Chemical compounds
|
KR100978904B1
(ko)
|
2001-12-14 |
2010-08-31 |
파마셋 인코포레이티드 |
바이러스 감염 치료용 n4-아실사이토신 뉴클레오사이드
|
WO2003051899A1
(en)
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Deazapurine nucleoside libraries and compounds
|
JP2005514401A
(ja)
|
2001-12-21 |
2005-05-19 |
マイクロロジックス バイオテック,インコーポレイテッド |
抗ウイルス性7−デアザl−ヌクレオシド
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
AU2003239463B2
(en)
|
2002-02-01 |
2007-10-18 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
|
CA2472028C
(en)
|
2002-02-01 |
2010-03-30 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
|
CA2370396A1
(en)
|
2002-02-01 |
2003-08-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor tri-peptides
|
US6642204B2
(en)
|
2002-02-01 |
2003-11-04 |
Boehringer Ingelheim International Gmbh |
Hepatitis C inhibitor tri-peptides
|
WO2003068244A1
(en)
|
2002-02-13 |
2003-08-21 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
US7285658B2
(en)
|
2002-02-28 |
2007-10-23 |
Biota, Inc. |
Nucleotide mimics and their prodrugs
|
WO2003073989A2
(en)
|
2002-02-28 |
2003-09-12 |
Biota, Inc. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
WO2003100017A2
(en)
|
2002-05-24 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
CN1671710A
(zh)
|
2002-06-04 |
2005-09-21 |
新创世纪药品公司 |
用作抗病毒药物的吡唑并[1,5-a]嘧啶化合物
|
EP1511757B1
(en)
|
2002-06-07 |
2015-11-04 |
Universitair Medisch Centrum Utrecht |
New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
|
EP1515971A2
(en)
|
2002-06-17 |
2005-03-23 |
Merck & Co., Inc. |
Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
AU2003248708A1
(en)
|
2002-06-17 |
2003-12-31 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds that include carbocyclic nucleosides and their use in gene modulation
|
EP1551421A2
(en)
|
2002-06-21 |
2005-07-13 |
Merck & Co. Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
CA2488484A1
(en)
|
2002-06-27 |
2004-01-08 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
CN1761677A
(zh)
|
2002-06-28 |
2006-04-19 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的修饰的2'和3'-核苷前药
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
RS114004A
(en)
|
2002-06-28 |
2007-02-05 |
Idenix (Cayman) Limited, |
Modified 2' and 3'-nucleoside produgs for treating flaviridae infections
|
BR0312278A
(pt)
|
2002-06-28 |
2007-06-19 |
Idenix Cayman Ltd |
éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae
|
PL374792A1
(en)
|
2002-06-28 |
2005-10-31 |
Idenix (Cayman) Limited |
2' and 3'-nucleoside prodrugs for treating flaviviridae infections
|
WO2004002977A1
(en)
|
2002-07-01 |
2004-01-08 |
Pharmacia & Upjohn Company Llc |
Inhibitors of hcv ns5b polymerase
|
EP1525186A1
(en)
|
2002-07-01 |
2005-04-27 |
Pharmacia & Upjohn Company LLC |
Inhibitors of hcv ns5b polymerase
|
EP1556399A4
(en)
|
2002-07-16 |
2007-09-26 |
Merck & Co Inc |
NUCLEOSIDE DERIVATIVES AS RNA-DEPENDENT VIRAL RNA POLYMERASE INHIBITORS
|
US7323449B2
(en)
|
2002-07-24 |
2008-01-29 |
Merck & Co., Inc. |
Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
CA2493816A1
(en)
|
2002-07-24 |
2004-01-29 |
Ptc Therapeutics, Inc. |
Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
|
JP2005538096A
(ja)
|
2002-07-25 |
2005-12-15 |
マイジェニックス インコーポレイテッド |
抗ウイルス7−デアザd−ヌクレオシドおよびその使用方法
|
WO2004014852A2
(en)
|
2002-08-12 |
2004-02-19 |
Bristol-Myers Squibb Company |
Iminothiazolidinones as inhibitors of hcv replication
|
PT1572095E
(pt)
|
2002-09-13 |
2015-10-13 |
Novartis Ag |
Β-l-2'-desoxinucleósidos para tratamento de estirpes resistentes de vhb
|
WO2004035571A1
(en)
|
2002-10-15 |
2004-04-29 |
Rigel Pharmaceuticals, Inc. |
Substituted indoles and their use as hcv inhibitors
|
US20040229840A1
(en)
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
AU2003290584B2
(en)
|
2002-11-01 |
2009-07-16 |
Viropharma Incorporated |
Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
|
BR0316363A
(pt)
|
2002-11-15 |
2005-10-04 |
Idenix Cayman Ltd |
Nucleosìdeos 2'-ramificado e mutação de flaviviridae
|
TWI332507B
(en)
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
MXPA05006230A
(es)
|
2002-12-12 |
2005-09-20 |
Idenix Cayman Ltd |
Proceso para la produccion de nucleosidos ramificados-2'.
|
US7259186B2
(en)
|
2002-12-17 |
2007-08-21 |
Abbott Laboratories |
Salts of fenofibric acid and pharmaceutical formulations thereof
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
AU2003225705A1
(en)
|
2003-03-07 |
2004-09-30 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
EP1745573A4
(en)
|
2003-03-20 |
2010-05-26 |
Microbiol Quimica Farmaceutica |
PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES
|
EP2033654B1
(en)
|
2003-04-16 |
2012-05-16 |
Bristol-Myers Squibb Company |
Process for resolving a mixture of alkyl ester enantiomers using an enzyme
|
AU2004233897A1
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
US7429565B2
(en)
|
2003-04-25 |
2008-09-30 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
AU2004233989A1
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
US20050261237A1
(en)
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
WO2004096210A1
(en)
|
2003-05-01 |
2004-11-11 |
Glaxo Group Limited |
Acylated indoline and tetrahydroquinoline derivatives as hcv inhibitors
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
MXPA05012101A
(es)
|
2003-05-09 |
2006-02-08 |
Boehringer Ingelheim Int |
Bolsillo de union al inhibidor de polimerasa ns5b del virus de la hepatitis c.
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020884A2
(en)
|
2003-05-14 |
2005-03-10 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
BRPI0410846B8
(pt)
|
2003-05-30 |
2021-05-25 |
Gilead Pharmasset Llc |
nucleosídeo e composição farmacêutica compreendendo o mesmo
|
US7507859B2
(en)
|
2003-06-16 |
2009-03-24 |
Fifth Base Llc |
Functional synthetic molecules and macromolecules for gene delivery
|
RU2243972C1
(ru)
|
2003-06-26 |
2005-01-10 |
Государственный научный центр вирусологии и биотехнологии "Вектор" |
Фосфорамидаты нуклеозидных аналогов - ингибиторы репродукции вируса иммунодефицита человека
|
KR20060035652A
(ko)
|
2003-06-30 |
2006-04-26 |
이데닉스 (케이만) 리미티드 |
β-L-2-데옥시 뉴클레오시드의 합성
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
DE602004028841D1
(de)
|
2003-07-25 |
2010-10-07 |
Centre Nat Rech Scient |
Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c
|
EP1660511B1
(en)
|
2003-08-27 |
2010-11-03 |
Biota Scientific Management Pty. Ltd. |
Novel tricyclic nucleosides or nucleotides as therapeutic agents
|
AR045769A1
(es)
|
2003-09-18 |
2005-11-09 |
Vertex Pharma |
Inhibidores de las serina proteasas, particularmente, la proteasa ns3-ns4a del vhc (virus hepatitis c)
|
US20050148534A1
(en)
|
2003-09-22 |
2005-07-07 |
Castellino Angelo J. |
Small molecule compositions and methods for increasing drug efficiency using compositions thereof
|
US7348389B2
(en)
|
2003-09-22 |
2008-03-25 |
E. I. Du Pont De Nemours And Company |
Method for achieving recoat adhesion over a fluorinated topcoat
|
US7491794B2
(en)
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
TWI375679B
(en)
|
2003-10-14 |
2012-11-01 |
Hoffmann La Roche |
Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
|
US7026339B2
(en)
|
2003-11-07 |
2006-04-11 |
Fan Yang |
Inhibitors of HCV NS5B polymerase
|
TW200528459A
(en)
|
2004-01-06 |
2005-09-01 |
Achillion Pharmaceuticals Inc |
Azabenzofuran substituted thioureas; inhibitors of viral replication
|
US20070155731A1
(en)
|
2004-01-28 |
2007-07-05 |
Gabor Butora |
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
|
EP1718150A1
(en)
|
2004-02-25 |
2006-11-08 |
The Government of the United States of America, represented by the Secretary, Department of Health and Human Services |
Methylation inhibitor compounds
|
US7157492B2
(en)
|
2004-02-26 |
2007-01-02 |
Wyeth |
Dibenzo chromene derivatives and their use as ERβ selective ligands
|
WO2005087788A2
(en)
|
2004-03-04 |
2005-09-22 |
The Regents Of The University Of California |
Methods for preparation of nucleoside phosphonate esters
|
AP2006003763A0
(en)
|
2004-03-30 |
2006-10-31 |
Intermune Inc |
Macrocyclic compounds as inhibitors of viral replication
|
GB0408995D0
(en)
|
2004-04-22 |
2004-05-26 |
Glaxo Group Ltd |
Compounds
|
RU2373923C2
(ru)
|
2004-06-08 |
2009-11-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтические композиции
|
EP1758453B1
(en)
|
2004-06-15 |
2014-07-16 |
Merck Sharp & Dohme Corp. |
C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
|
WO2006000922A2
(en)
|
2004-06-23 |
2006-01-05 |
Idenix (Cayman) Limited |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
EP1773355B1
(en)
|
2004-06-24 |
2014-06-25 |
Merck Sharp & Dohme Corp. |
Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
|
US7217523B2
(en)
|
2004-07-02 |
2007-05-15 |
Regents Of The University Of Minnesota |
Nucleoside phosphoramidates and nucleoside phosphoramidases
|
KR101236669B1
(ko)
|
2004-07-21 |
2013-02-22 |
길리어드 파마셋 엘엘씨 |
알킬-치환된 2-데옥시-2-플루오로-d-리보퓨라노실피리미딘 및 퓨린 및 그 유도체의 제조
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
SI2258376T1
(sl)
|
2004-07-27 |
2019-04-30 |
Gilead Sciences, Inc. |
Analogi fosfonata spojin inhibitorjev HIV
|
US7348425B2
(en)
|
2004-08-09 |
2008-03-25 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
US7153848B2
(en)
|
2004-08-09 |
2006-12-26 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
CN101048403B
(zh)
|
2004-08-23 |
2010-06-16 |
弗·哈夫曼-拉罗切有限公司 |
杂环的抗病毒化合物
|
ES2327252T3
(es)
|
2004-08-23 |
2009-10-27 |
F. Hoffmann-La Roche Ag |
4'-azido nucleosidos antivirales.
|
WO2006029081A2
(en)
|
2004-09-02 |
2006-03-16 |
Neopharm, Inc. |
Nucleoside-lipid conjugates, their method of preparation and uses thereof
|
RU2433124C2
(ru)
|
2004-09-14 |
2011-11-10 |
Фармассет, Инк. |
Способ получения 2'-фтор-2'-алкилзамещенных или других замещенных рибофуранозилпиримидинов и пуринов и их производных
|
FR2875409B1
(fr)
|
2004-09-17 |
2010-05-07 |
Sanofi Aventis |
Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose
|
BRPI0515896A
(pt)
|
2004-09-24 |
2008-08-12 |
Idenix Cayman Ltd E Ct Nat De |
composto ou um sal ou éster farmaceuticamente aceitável do mesmo, método para o tratamento ou profilaxia de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus, e, composição farmacêutica para o tratamento de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus
|
RU2380101C2
(ru)
|
2004-09-30 |
2010-01-27 |
Тиботек Фармасьютикалз Лтд. |
Бициклические пиримидины, ингибирующие hcv
|
EP1804812A4
(en)
|
2004-10-21 |
2009-09-02 |
Merck & Co Inc |
FLUORINATED PYRROLO [2,3-D] PYRIMIDIN NUCLEOSIDES FOR THE TREATMENT OF RNA-DEPENDENT RNA VIRUS INFECTIONS
|
CA2585079A1
(en)
|
2004-10-29 |
2006-05-11 |
Biocryst Pharmaceuticals, Inc. |
Therapeutic furopyrimidines and thienopyrimidines
|
JP2008523082A
(ja)
|
2004-12-09 |
2008-07-03 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
抗菌活性および抗癌活性を有するヌクレオチド
|
EP1828217A2
(en)
|
2004-12-16 |
2007-09-05 |
Febit Biotech GmbH |
Polymerase-independent analysis of the sequence of polynucleotides
|
WO2006065590A2
(en)
|
2004-12-16 |
2006-06-22 |
Xtl Biopharmaceuticals Inc. |
Pyridine and pyrimidine antiviral compositions
|
EP1674104A1
(en)
|
2004-12-24 |
2006-06-28 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Uridine derivatives as antiviral drugs against a flaviviridae, especially HCV
|
CN100528875C
(zh)
|
2005-02-18 |
2009-08-19 |
美德(江西)生物科技有限公司 |
无结晶型态的印地普隆及其制备方法
|
WO2006093801A1
(en)
|
2005-02-25 |
2006-09-08 |
Abbott Laboratories |
Thiadiazine derivatives useful as anti-infective agents
|
JP2008531703A
(ja)
|
2005-02-28 |
2008-08-14 |
ジェネラブズ テクノロジーズ インコーポレーティッド |
ウイルス感染症の治療のための三環式ヌクレオシドプロドラッグ
|
CA2602294C
(en)
|
2005-03-25 |
2015-02-24 |
Tibotec Pharmaceuticals Ltd. |
Heterobicylic inhibitors of hvc
|
WO2006116557A1
(en)
|
2005-04-25 |
2006-11-02 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
WO2006121820A1
(en)
|
2005-05-05 |
2006-11-16 |
Valeant Research & Development |
Phosphoramidate prodrugs for treatment of viral infection
|
TW200716631A
(en)
|
2005-05-12 |
2007-05-01 |
Tibotec Pharm Ltd |
Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
|
AR056347A1
(es)
|
2005-05-12 |
2007-10-03 |
Tibotec Pharm Ltd |
Uso de compuestos de pteridina para fabricar medicamentos y composiciones farmaceuticas
|
WO2007027248A2
(en)
|
2005-05-16 |
2007-03-08 |
Valeant Research & Development |
3', 5' - cyclic nucleoside analogues for treatment of hcv
|
US8143288B2
(en)
|
2005-06-06 |
2012-03-27 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
US20060293752A1
(en)
|
2005-06-27 |
2006-12-28 |
Missoum Moumene |
Intervertebral disc prosthesis and associated methods
|
NZ565059A
(en)
|
2005-07-25 |
2011-08-26 |
Intermune Inc |
Novel macrocyclic inhibitors of hepatitus C virus replication
|
KR101381387B1
(ko)
|
2005-07-29 |
2014-04-11 |
메디비르 아베 |
C형 간염 바이러스의 마크로사이클릭 억제제
|
BRPI0614638A2
(pt)
|
2005-07-29 |
2011-04-12 |
Tibotec Pharm Ltd |
compostos inibidores macrocìclicos do vìrus da hepatite c, uso dos mesmos, processo para a preparação dos mesmos, combinação e composição farmacêutica
|
TWI383980B
(zh)
|
2005-07-29 |
2013-02-01 |
Tibotec Pharm Ltd |
C型肝炎病毒之大環抑制劑
|
JP5230417B2
(ja)
|
2005-07-29 |
2013-07-10 |
テイボテク・フアーマシユーチカルズ |
C型肝炎ウイルスの大員環インヒビター
|
PE20070211A1
(es)
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
CN101287472B
(zh)
|
2005-08-15 |
2011-10-12 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的4'-取代前核苷酸的氨基磷酸酯类化合物
|
GB0519478D0
(en)
|
2005-09-23 |
2005-11-02 |
Glaxo Group Ltd |
Compounds
|
GB0519488D0
(en)
|
2005-09-23 |
2005-11-02 |
Glaxo Group Ltd |
Compounds
|
JP4979710B2
(ja)
|
2005-12-09 |
2012-07-18 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
抗ウイルスヌクレオシド
|
CA2633541A1
(en)
|
2005-12-12 |
2007-06-21 |
Genelabs Technologies, Inc. |
N-(6-membered aromatic ring)-amido anti-viral compounds
|
RU2441869C2
(ru)
|
2005-12-21 |
2012-02-10 |
Эбботт Лэборетриз |
Противовирусные соединения
|
GB0602046D0
(en)
|
2006-02-01 |
2006-03-15 |
Smithkline Beecham Corp |
Compounds
|
WO2007092000A1
(en)
|
2006-02-06 |
2007-08-16 |
Bristol-Myers Squibb Company |
Inhibitors of hcv replication
|
EP1832281A1
(en)
|
2006-03-10 |
2007-09-12 |
Abbott GmbH & Co. KG |
Process for producing a solid dispersion of an active ingredient
|
JP2009526850A
(ja)
|
2006-02-14 |
2009-07-23 |
メルク エンド カムパニー インコーポレーテッド |
Rna依存性rnaウイルス感染を治療するためのヌクレオシドアリールホスホルアミデート
|
BRPI0707945A2
(pt)
|
2006-02-17 |
2011-05-17 |
Pfizer Ltd |
derivados de 3-deazapurina como modulares de tlr7
|
JP2009530415A
(ja)
|
2006-03-20 |
2009-08-27 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
医薬組成物
|
US8895531B2
(en)
|
2006-03-23 |
2014-11-25 |
Rfs Pharma Llc |
2′-fluoronucleoside phosphonates as antiviral agents
|
WO2007140254A2
(en)
|
2006-05-25 |
2007-12-06 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
|
US8891379B2
(en)
|
2006-06-02 |
2014-11-18 |
Riverbed Technology, Inc. |
Traffic flow inference based on link loads and gravity measures
|
AU2007275860C1
(en)
|
2006-07-07 |
2014-06-12 |
Gilead Sciences, Inc. |
Modulators of pharmacokinetic properties of therapeutics
|
EP1881001A1
(en)
|
2006-07-20 |
2008-01-23 |
Tibotec Pharmaceuticals Ltd. |
HCV NS-3 serine protease inhibitors
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8303944B2
(en)
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
AU2007307057B2
(en)
|
2006-10-10 |
2011-09-15 |
F. Hoffmann La-Roche Ag |
Preparation of nucleosides ribofuranosyl pyrimidines
|
PL216525B1
(pl)
|
2006-10-17 |
2014-04-30 |
Ct Badań Molekularnych I Makromolekularnych Polskiej Akademii Nauk |
5'-O-[(N-acylo)amidoditiofosforano] nukleozydy oraz sposób wytwarzania 5'-O-[(N-acylo)amidofosforano]-,5'-O-[(N-acylo)amidotiofosforano]-, 5'-O-[(N-acylo)amidoditiofosforano]nukleozydów
|
GB0623493D0
(en)
|
2006-11-24 |
2007-01-03 |
Univ Cardiff |
Chemical compounds
|
CA2671975C
(en)
*
|
2006-12-07 |
2013-10-29 |
Daiichi Sankyo Company, Limited |
Film-coated preparation having improved stability
|
WO2008079206A1
(en)
|
2006-12-20 |
2008-07-03 |
Merck & Co., Inc. |
Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
EP2124555B1
(en)
|
2007-01-05 |
2015-07-08 |
Merck Sharp & Dohme Corp. |
Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
|
WO2008104408A2
(en)
|
2007-02-27 |
2008-09-04 |
K. U. Leuven Research & Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
US7741347B2
(en)
|
2007-05-17 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
GB0709791D0
(en)
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
EP2168959A1
(en)
|
2007-06-19 |
2010-03-31 |
Kyorin Pharmaceutical Co., Ltd. |
Pyridazinone derivative and pde inhibitor containing the same as active ingredient
|
EA025794B1
(ru)
|
2007-06-29 |
2017-01-30 |
Джилид Сайэнс, Инк. |
Противовирусные соединения
|
CN101108870A
(zh)
|
2007-08-03 |
2008-01-23 |
冷一欣 |
核苷磷酸酯类化合物及制备方法和应用
|
US7728027B2
(en)
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
US8629171B2
(en)
|
2007-08-08 |
2014-01-14 |
Bristol-Myers Squibb Company |
Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
|
JO2778B1
(en)
|
2007-10-16 |
2014-03-15 |
ايساي انك |
Certain vehicles, installations and methods
|
TW200922549A
(en)
|
2007-10-19 |
2009-06-01 |
Abbott Gmbh & Amp Co Kg |
Solid dispersion product containing N-aryl urea-based compound
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
CN101998952B
(zh)
|
2008-02-12 |
2014-10-08 |
百时美施贵宝公司 |
丙型肝炎病毒抑制剂
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
JP5312486B2
(ja)
|
2008-02-13 |
2013-10-09 |
ブリストル−マイヤーズ スクイブ カンパニー |
C型肝炎ウイルス阻害剤
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8227431B2
(en)
|
2008-03-17 |
2012-07-24 |
Hetero Drugs Limited |
Nucleoside derivatives
|
WO2009142822A2
(en)
|
2008-03-26 |
2009-11-26 |
Alnylam Pharmaceuticals, Inc. |
2-f modified rna interference agents
|
CA2722308C
(en)
|
2008-04-15 |
2024-02-27 |
Rfs Pharma, Llc. |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
WO2010004343A1
(en)
|
2008-07-10 |
2010-01-14 |
Prosidion Limited |
Piperidinyl gpcr agonists
|
WO2010009121A2
(en)
|
2008-07-15 |
2010-01-21 |
University Of Florida Research Foundation, Inc. |
Colon stem cells associated with colitis and colorectal cancer and methods of use
|
JP2011530532A
(ja)
|
2008-08-07 |
2011-12-22 |
シェーリング コーポレイション |
固体分子分散物中のhcvプロテアーゼインヒビターの薬学的処方物
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US20100256184A1
(en)
*
|
2008-08-13 |
2010-10-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
RS56894B1
(sr)
*
|
2008-08-13 |
2018-04-30 |
Vertex Pharma |
Farmaceutska kompozicija n-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksohinolin-3-karboksamida i njeno ordiniranje
|
US8383094B2
(en)
|
2008-10-01 |
2013-02-26 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US20110229438A1
(en)
|
2008-10-09 |
2011-09-22 |
Anadys Pharmaceuticals, Inc. |
Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds
|
US8729077B2
(en)
|
2008-11-28 |
2014-05-20 |
Glaxosmithkline Llc |
Anti-viral compounds, compositions, and methods of use
|
SG171891A1
(en)
|
2008-12-03 |
2011-07-28 |
Presidio Pharmaceuticals Inc |
Inhibitors of hcv ns5a
|
PT2373172E
(pt)
|
2008-12-03 |
2013-10-21 |
Presidio Pharmaceuticals Inc |
Inibidores de ns5a de hcv
|
SG194404A1
(en)
|
2008-12-23 |
2013-11-29 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
WO2010075549A2
(en)
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Nucleoside phosphoramidates
|
US8551973B2
(en)
|
2008-12-23 |
2013-10-08 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
RU2011127079A
(ru)
|
2009-01-07 |
2013-02-20 |
Сайнексис, Инк. |
Комбинация производного циклоспорина и нуклеозидов для лечения инфекции вирусом гепатита с
|
WO2010091413A1
(en)
|
2009-02-09 |
2010-08-12 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
WO2010094977A1
(en)
|
2009-02-23 |
2010-08-26 |
Arrow Therapeutics Limited |
Novel biphenyl compounds useful for the treatment of hepatitis c
|
CA2753313A1
(en)
|
2009-02-23 |
2010-08-26 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
KR101713066B1
(ko)
|
2009-02-27 |
2017-03-07 |
얀센 파마슈티칼스 인코포레이티드 |
Hcv 마크로사이클릭 저해제의 무정형 염
|
BRPI1007836A2
(pt)
|
2009-02-27 |
2015-09-01 |
Enanta Phamaceuticals Inc |
Inibidores do vírus c da hepatite
|
AP2011005929A0
(en)
|
2009-03-20 |
2011-10-31 |
Alios Biopharma Inc |
Substituted nucleoside and nucleotide analogs.
|
UA108351C2
(uk)
|
2009-03-27 |
2015-04-27 |
|
Інгібітори реплікації вірусу гепатиту c
|
WO2010111534A1
(en)
|
2009-03-27 |
2010-09-30 |
Presidio Pharmaceuticals, Inc. |
Fused ring inhibitors of hepatitis c
|
EP2410841A4
(en)
|
2009-03-27 |
2012-10-24 |
Presidio Pharmaceuticals Inc |
SUBSTITUTED BICYCLIC HCV INHIBITORS
|
US8796466B2
(en)
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
TWI476190B
(zh)
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
TW201038559A
(en)
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CN102459165B
(zh)
|
2009-04-15 |
2015-09-02 |
Abbvie公司 |
抗病毒化合物
|
JP2012524761A
(ja)
|
2009-04-24 |
2012-10-18 |
テイボテク・フアーマシユーチカルズ |
ジアリールエーテル類
|
WO2010132538A1
(en)
|
2009-05-12 |
2010-11-18 |
Schering Corporation |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
TW202042807A
(zh)
|
2009-05-13 |
2020-12-01 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
EP2435421A1
(en)
|
2009-05-29 |
2012-04-04 |
Schering Corporation |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8211928B2
(en)
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2010138791A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
CN103819459B
(zh)
|
2009-06-11 |
2017-05-17 |
艾伯维巴哈马有限公司 |
抗病毒化合物
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
WO2010148006A1
(en)
|
2009-06-16 |
2010-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
WO2011004276A1
(en)
|
2009-07-06 |
2011-01-13 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
CA2767887A1
(en)
|
2009-07-16 |
2011-01-20 |
Vertex Pharmaceuticals Incorporated |
Benzimidazole analogues for the treatment or prevention of flavivirus infections
|
RU2538507C2
(ru)
|
2009-08-07 |
2015-01-10 |
Тиботек Фармасьютикалз |
Фенилэтинильные производные в качестве ингибиторов вируса гепатита с
|
CN102471324B
(zh)
|
2009-08-07 |
2014-12-17 |
泰博特克药品公司 |
作为丙型肝炎病毒抑制剂的双苯并咪唑衍生物
|
FR2949465B1
(fr)
|
2009-09-01 |
2011-08-12 |
Pf Medicament |
Derives chromones, leur procede de preparation et leurs applications therapeutiques
|
US20120172368A1
(en)
|
2009-09-03 |
2012-07-05 |
Koen Vandyck |
Bis-Benzimidazole Derivatives
|
EP3006441A1
(en)
|
2009-09-04 |
2016-04-13 |
Janssen Pharmaceuticals, Inc. |
Ns5a inhibitors
|
EP2475254A4
(en)
|
2009-09-11 |
2013-05-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
US9156818B2
(en)
|
2009-09-11 |
2015-10-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8415374B2
(en)
|
2009-10-12 |
2013-04-09 |
Bristol-Myers Squibb Company |
Combinations of hepatitis C virus inhibitors
|
WO2011050146A1
(en)
|
2009-10-23 |
2011-04-28 |
Glaxosmithkline Llc |
Chemical compounds
|
UA108211C2
(uk)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
US20110274648A1
(en)
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20110269956A1
(en)
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20110281910A1
(en)
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
CA2782024A1
(en)
|
2009-11-25 |
2011-06-03 |
Schering Corporation |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
US20110137633A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Anti-viral compounds and methods of identifying the same
|
US8476225B2
(en)
|
2009-12-04 |
2013-07-02 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US8653070B2
(en)
|
2009-12-14 |
2014-02-18 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8377980B2
(en)
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
AU2010330862B2
(en)
|
2009-12-18 |
2015-06-25 |
Idenix Pharmaceuticals, Inc. |
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
|
CN102791687B
(zh)
|
2009-12-18 |
2015-02-11 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
JP2013515068A
(ja)
|
2009-12-22 |
2013-05-02 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ウイルス性疾患の治療のための縮合三環式化合物およびその使用方法
|
JP2013515746A
(ja)
|
2009-12-24 |
2013-05-09 |
ヴァーテックス ファーマシューティカルズ、 インコーポレイテッド |
フラビウイルス感染症の治療又は予防のための類似体
|
US8362020B2
(en)
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2011091446A1
(en)
|
2010-01-22 |
2011-07-28 |
Glaxosmithkline Llc |
Chemical compounds
|
EA201290882A1
(ru)
|
2010-03-09 |
2013-04-30 |
Мерк Шарп Энд Домэ Корп. |
Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
|
BR112012024884A2
(pt)
|
2010-03-31 |
2016-10-18 |
Gilead Pharmasset Llc |
síntese estereosseletiva de ativos contendo fósforo
|
US9125904B1
(en)
|
2010-05-11 |
2015-09-08 |
Achillion Pharmaceuticals, Inc. |
Biphenyl imidazoles and related compounds useful for treating HCV infections
|
US20110312996A1
(en)
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
JP2013526581A
(ja)
|
2010-05-21 |
2013-06-24 |
ギリアード サイエンシーズ, インコーポレイテッド |
ヘテロ環式フラビウイルス科ウイルス阻害剤
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
AR084393A1
(es)
|
2010-06-10 |
2013-05-15 |
Gilead Sciences Inc |
Metodos para tratar el virus de la hepatitis c, composicion, uso, combinacion, kit y uno o mas compuestos anti vhc
|
EP2963034A1
(en)
|
2010-08-26 |
2016-01-06 |
RFS Pharma, LLC. |
Potent and selective inhibitors of hepatitis c virus
|
CA2811662A1
(en)
|
2010-09-29 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Tetracyclic indole derivatives for treating hepatitis c virus infection
|
WO2012048421A1
(en)
|
2010-10-14 |
2012-04-19 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibitor compounds
|
US20120107278A1
(en)
|
2010-10-29 |
2012-05-03 |
Pharmasset, Inc. |
Abbreviated hcv therapy for hcv infected patients with il28b c/c genotype
|
CA2817840A1
(en)
|
2010-11-17 |
2012-05-24 |
Gilead Sciences, Inc. |
Antiviral compounds
|
JP5891241B2
(ja)
|
2010-12-20 |
2016-03-22 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hcvを処置するための組合せ
|
WO2012087976A2
(en)
|
2010-12-21 |
2012-06-28 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
EP2562223A1
(de)
|
2011-08-26 |
2013-02-27 |
Sika Technology AG |
Zweikomponentige Zusammensetzung auf Basis von silanfunktionellen Polymeren
|
AU2012308295B2
(en)
|
2011-09-16 |
2017-10-26 |
Gilead Pharmasset Llc |
Methods for treating HCV
|
ES2572328B1
(es)
|
2011-10-21 |
2017-08-24 |
Abbvie Inc. |
Combinación de al menos dos agentes antivirales de acción directa y ribavirina pero no interferón, para su uso en el tratamiento del vhc
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
US8492386B2
(en)
|
2011-10-21 |
2013-07-23 |
Abbvie Inc. |
Methods for treating HCV
|
DE202012012954U1
(de)
|
2011-10-21 |
2014-08-12 |
Abbvie Inc. |
Eine Kombination aus mindestens zwei direkt wirkenden antiviralen Wirkstoffen (DAAs) für die Verwendung zur Behandlung von HCV
|
US20130109647A1
(en)
*
|
2011-10-31 |
2013-05-02 |
Gilead Pharmasset Llc |
Methods and compositions for treating hepatitis c virus
|
SI2907816T1
(sl)
|
2011-11-16 |
2018-10-30 |
Gilead Pharmasset Llc |
Kondenzirani imidazolilimidazoli kot protivirusni sestavki
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
CN104010631B
(zh)
*
|
2011-12-29 |
2016-08-17 |
艾伯维公司 |
包含hcv抑制剂的固体组合物
|
US9034832B2
(en)
|
2011-12-29 |
2015-05-19 |
Abbvie Inc. |
Solid compositions
|
US9079887B2
(en)
|
2012-05-16 |
2015-07-14 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
WO2013177188A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
US8969588B2
(en)
|
2012-06-05 |
2015-03-03 |
Gilead Pharmasset Llc |
Solid forms of an antiviral compound
|
US9056860B2
(en)
|
2012-06-05 |
2015-06-16 |
Gilead Pharmasset Llc |
Synthesis of antiviral compound
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
UA119315C2
(uk)
|
2012-07-03 |
2019-06-10 |
Гіліад Фармассет Елелсі |
Інгібітори вірусу гепатиту с
|
US8841340B2
(en)
|
2012-08-17 |
2014-09-23 |
Gilead Sciences, Inc. |
Solid forms of an antiviral compound
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
LT2950786T
(lt)
|
2013-01-31 |
2020-03-10 |
Gilead Pharmasset Llc |
Dviejų antivirusinių junginių preparatų kompozicija
|
TW201434949A
(zh)
|
2013-01-31 |
2014-09-16 |
Nitto Denko Corp |
環氧組合物及環氧樹脂成形體
|
US20140343008A1
(en)
|
2013-05-16 |
2014-11-20 |
Gilead Pharmasset Llc |
Hepatitis c treatment
|
ES2792503T3
(es)
|
2013-08-27 |
2020-11-11 |
Gilead Pharmasset Llc |
Formulación combinada de dos compuestos antivirales
|
WO2015030854A1
(en)
|
2013-08-27 |
2015-03-05 |
Gilead Pharmasset Llc |
Solid dispersion formulation of an antiviral compound
|
WO2015084741A2
(en)
|
2013-12-02 |
2015-06-11 |
Gilead Pharmasset Llc |
Methods of treating hepatitis c virus infection in subjects with cirrhosis
|
TW202014413A
(zh)
|
2014-06-11 |
2020-04-16 |
美商基利法瑪席特有限責任公司 |
製備抗病毒化合物之方法
|
TWI721947B
(zh)
|
2014-06-11 |
2021-03-21 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物的固態形式
|
JP2016051146A
(ja)
|
2014-09-02 |
2016-04-11 |
ウシオ電機株式会社 |
光検出装置
|